ERBB2 and ductal breast carcinoma in situ: Although there was limited data regarding the effect of NST on DCIS associated with TNBC, the rate of eradication observed was comparable to HER2-positive disease (45% vs. 46%, p = 0.99), again significantly higher than ER-positive disease.